• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.66% Nasdaq Down 1.05%

    More On ANP.AX

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Antisense Therapeutics Ltd. (ANP.AX)

    -ASX
    0.09 Up 0.00(2.41%) Sep 4, 12:09AM EDT
    Add to Portfolio
    Prev Close:0.08
    Open:0.08
    Bid:0.08
    Ask:0.09
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.08 - 0.09
    52wk Range:0.08 - 0.17
    Volume:26,824
    Avg Vol (3m):151,853
    Market Cap:15.00M
    P/E (ttm):21.25
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in AUD.

    Headlines

    • No Headlines available for ANP.AX at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Antisense Therapeutics Limited engages in the research, development, and commercialization of novel antisense pharmaceuticals in Australia. The company’s product pipeline comprises ATL1102, an antisense inhibitor targeting VLA-4 for the treat... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback